Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXXVIII | Pages 22 - 22
1 Sep 2012
Full Access
By next summer the number of patients in the tranexamic acid group will be much higher, probably around 50–60. Tranexamic acid has been extensively studied in single total knee and total hip replacement patients. It has been found to reduce blood loss and transfusion rates, with no increase in the rate of venous thromboembolism. This study was undertaken to determine whether tranexamic acid reduces blood loss and the rate of blood transfusion after bilateral total knee replacement, which has a much higher transfusion rate.Abstract
Purpose
Results 1 - 1 of 1
Results per page:
